No black box warning on record for Hydrochlorothiazide

As of the latest FDA labeling reviewed, Hydrochlorothiazide (hydrochlorothiazide) does not carry a black box warning. Standard warnings and precautions still apply — see the full Hydrochlorothiazide medicine page for the complete safety profile.

Other warnings & precautions

Electrolyte Monitoring: Monitor serum electrolytes (Na, K, Cl, HCO3), BUN, creatinine, and glucose periodically during treatment.
Hypokalemia Risk: Potassium-wasting effect is a major concern. Dietary potassium supplementation or a potassium-sparing diuretic may be needed.
Elderly Patients: Higher risk of severe hyponatremia and falls. Use lowest effective dose and monitor electrolytes more frequently.
Diabetic Patients: Can worsen glycemic control. Monitor blood glucose.
Gout: Can precipitate acute gout attacks in susceptible patients by increasing uric acid.

No black box warning on record for Hydrochlorothiazide

Other warnings & precautions

Electrolyte Monitoring: Monitor serum electrolytes (Na, K, Cl, HCO3), BUN, creatinine, and glucose periodically during treatment.
Hypokalemia Risk: Potassium-wasting effect is a major concern. Dietary potassium supplementation or a potassium-sparing diuretic may be needed.
Elderly Patients: Higher risk of severe hyponatremia and falls. Use lowest effective dose and monitor electrolytes more frequently.
Diabetic Patients: Can worsen glycemic control. Monitor blood glucose.
Gout: Can precipitate acute gout attacks in susceptible patients by increasing uric acid.

Hydrochlorothiazide Black Box Warning

No black box warning on record for Hydrochlorothiazide

Other warnings & precautions

Hydrochlorothiazide Black Box Warning

No black box warning on record for Hydrochlorothiazide

Other warnings & precautions